Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 September 2019 | Story Ruan Bruwer | Photo Supplied
Kovsies Women Cross-Country Team Marné Mentz, Vicky Oelofse, and Channah du Plessis
Marné Mentz, Ts’epang Sello, and Tyler Beling played a huge role in Kovsies' cross-country champions win.

After coming within a whisker of claiming the title in 2018, the University of the Free State’s (UFS) runners ensured that the University Sports South Africa (USSA) cross-country trophy comes to Bloemfontein in 2019.

Kovsies are the new national student cross-country champions after they (men and women combined) won the USSA Championships in Nelspruit on Saturday, 21 September. Kovsies and the University of Johannesburg (UJ) both finished with three gold medals at the same event in 2018. UJ finished with nine overall medals compared to the eight (three gold, two silver, and three silver) of the UFS, who had to settle for second place. In 2017, the UFS finished third.

The Kovsie women’s team played a huge role in carrying the team to the top of the medal table, winning four golds. They won the 4 km and 10 km women’s team competitions as well as the road relay. The top three places by the runners of a university determined the team winner.

Marné Mentz UFS Cross-Country

Marné Mentz’s gold medal in the four-kilometre race at the
USSA Cross Country Championships helped the Kovsies
win the overall title.

Marné Mentz (first), Vicky Oelofse (fifth), and Channah du Plessis (sixth) dominated the four-kilometre race. In the 10 km, Ts’epang Sello (third), Tyler Beling (sixth), and Lizandré Mulder (seventh) did enough to ensure another gold for the Free State students. Mentz, Sello, and Beling jointly took first place in the road relay.

In the 10-km race for men, Kovsies came fifth, with Victor Makhabesela the best performer (finishing ninth). Pakiso Mthembu, one of the contenders for the medal who won the silver medal at the National Cross Country Championships two weeks before, had to withdraw after 7 km in the race due to an injury.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept